Navigation Links
Novel handheld device detects anthrax with outstanding accuracy and reliability

Baltimore, MD, and Christchurch, NZ June 25, 2009 Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker (pronounced "seeker") portable bacterial detection device in discriminating between anthrax spores and similar-looking hoax substances. The data show that in over two weeks of testing at the Midwest Research Institute in Florida, the company's Ceeker scanner accurately identified 100% of the anthrax samples used and was correct in 95% of tests involving hoax substances. These test results are consistent with similar results produced last year by a New Zealand forensic testing agency, Environmental Science and Research (ESR).

"We knew that our innovative Ceeker is capable of producing outstanding results in distinguishing between anthrax and look-alike hoax substances, and now we have definitive data confirming its performance," said Andrew Rudge, Ph.D., Chief Executive Officer of Veritide. "Even better, these extraordinary results were generated by a small portable handheld system that requires no special skills or training to operate and that can produce a result within minutes, enabling first responders to rapidly determine whether the situation is a nuisance or a major threat to public health."

The Ceeker employs optical detection technology developed at New Zealand's University of Canterbury. It uses ultraviolet light and special algorithms to detect bacterial spores and provides test results within minutes, without the need for wet chemistry or analytic processes that can be difficult to handle in the field. The Ceeker is capable of producing test results from very small amounts of sample and does not consume or destroy the sample being tested, allowing it to be re-analyzed later for forensic applications.

In contrast, existing detection approaches require longer and more complex processing to distinguish anthrax from other substances (between 30 minutes and three days), their accuracy is inferior to the Ceeker and the sample is typically destroyed during testing.

The new data will be presented on June 26, 2009 at Biodetection Technologies 2009 by Professor Lou Reinisch, an inventor of the Ceeker technology and Professor of Physics and Department Head at Jacksonville State University in Alabama. Prof. Reinisch noted, "It is gratifying to present these outstanding results from a system that has so much potential to reduce the large costs and losses in productivity and peace of mind caused by our current inability to easily distinguish between anthrax spores and harmless white powder. These new data definitively confirm the validity of the detection concepts underlying the Ceeker and should help fuel its wider use among such first responders as fire and police departments, HazMat teams, postal services, port and airport security, and defense and military authorities."

John Delaney is Captain, Arlington County, Virginia Fire Department and Manager, National Medical Response Team-National Capital Region, home to the Pentagon and many other major U.S. government and corporate facilities. Capt. Delaney commented, "With responsibility for helping to ensure the safety of the hundreds of thousands of people who live and work in the Capital Region, my department welcomes the availability of technologically advanced solutions that enhance our ability to carry out our mission. The Veritide Ceeker is an excellent exampleit is extremely versatile, easy-to-use and fastresults are ready in minutes. Most importantly, the new test data being presented this week confirm that the Ceeker is very reliable, enabling front-line decision makers to rapidly and confidently validate initial threat assessments that can ultimately have a far-reaching impact on public safety and well-being. The National Capital Region generally receives on average one alert a day or more regarding the potential presence of anthrax, so this device can only enhance our first responder capabilities and accuracy."

The Ceeker has also been previously validated by forensic laboratory ESR, which conducted multiple rounds of testing using anthrax simulants and hoax substances. The successful U.S. test results have triggered significant sales from U.S. customers who had pre-ordered the Ceeker but were waiting for positive direct anthrax testing results before proceeding.

Dr. Rudge added, "Achieving these results represents a significant milestone and positions Veritide as the first company to offer proven technology capable of accurately and reliably detecting lethal anthrax spores, and to do so without destroying the sample. These new testing results are expected to unlock large potential markets for Veritide in North America and around the globe. We currently are in the process of identifying potential partners and additional investors to ensure this important technology is available worldwide."


Contact: Barbara Lindheim
BioCom Partners

Related biology technology :

1. Novel Technology Breaks Through Cancer Pain
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart Infections Caused by the Most Problematic UK Organisms, Including MRSA
6. NIST team develops novel method for nanostructured polymer thin films
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. Arpida Invited to Present Preclinical Data on Novel Topical Antibiotic AR-2474 at ICAAC
9. European Expert Consortium Combines Forces to Develop a Novel Pandemic Influenza Vaccine
10. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
11. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Vancouver ... lancet that features Owen Mumford,s unique Comfort Zone Technology®. ... Unistik® Touch is a touch activated lancet that features ... Owen Mumford, a leading medical device manufacturer, today unveils ... available initially in the US before expanding out to ...
(Date:12/1/2015)... Dec. 1, 2015 Today the Allen Institute ... Seattle,s South Lake Union neighborhood, the ... Mercer Street and Westlake Avenue North, the 270,000 square ... Institute for Brain Science and the Allen Institute for ... and founder of the Allen Institute. "We started by ...
(Date:12/1/2015)... CAMBRIDGE, Mass. , Dec. 1, 2015 ... and the McGovern Institute for Brain Research at MIT ... system that significantly cut down on "off-target" editing errors. ... issues in the use of genome editing. ... report that changing three of the approximately 1,400 amino ...
(Date:12/1/2015)... -- Twist Bioscience, a company focused on synthetic DNA, today announced ... selected as one of Foreign Policy,s 100 Leading ... of life . Each year, Foreign Policy selects ... have changed lives and are shaping the world. ... to be recognized among these incredible global leaders," said Leproust. ...
Breaking Biology Technology:
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):